JPWO2023168367A5 - - Google Patents

Info

Publication number
JPWO2023168367A5
JPWO2023168367A5 JP2024551891A JP2024551891A JPWO2023168367A5 JP WO2023168367 A5 JPWO2023168367 A5 JP WO2023168367A5 JP 2024551891 A JP2024551891 A JP 2024551891A JP 2024551891 A JP2024551891 A JP 2024551891A JP WO2023168367 A5 JPWO2023168367 A5 JP WO2023168367A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
compound
independently
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024551891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507820A (ja
JP2025507820A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063623 external-priority patent/WO2023168367A1/en
Publication of JP2025507820A publication Critical patent/JP2025507820A/ja
Publication of JPWO2023168367A5 publication Critical patent/JPWO2023168367A5/ja
Publication of JP2025507820A5 publication Critical patent/JP2025507820A5/ja
Pending legal-status Critical Current

Links

JP2024551891A 2022-03-02 2023-03-02 キノリンcGasアンタゴニスト化合物 Pending JP2025507820A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263315968P 2022-03-02 2022-03-02
US63/315,968 2022-03-02
US202363478467P 2023-01-04 2023-01-04
US63/478,467 2023-01-04
PCT/US2023/063623 WO2023168367A1 (en) 2022-03-02 2023-03-02 QUINOLINE cGAS ANTAGONIST COMPOUNDS

Publications (3)

Publication Number Publication Date
JP2025507820A JP2025507820A (ja) 2025-03-21
JPWO2023168367A5 true JPWO2023168367A5 (https=) 2026-03-10
JP2025507820A5 JP2025507820A5 (https=) 2026-03-10

Family

ID=85781707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024551891A Pending JP2025507820A (ja) 2022-03-02 2023-03-02 キノリンcGasアンタゴニスト化合物

Country Status (11)

Country Link
US (3) US12281078B2 (https=)
EP (1) EP4486734A1 (https=)
JP (1) JP2025507820A (https=)
KR (1) KR20250004639A (https=)
CN (1) CN119137112A (https=)
AU (1) AU2023228915A1 (https=)
CA (1) CA3253386A1 (https=)
IL (1) IL315346A (https=)
MX (1) MX2024010674A (https=)
TW (1) TW202342021A (https=)
WO (1) WO2023168367A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230062845A (ko) 2020-09-03 2023-05-09 이뮨센서 테라퓨틱스, 인코포레이티드 퀴놀린 cgas 길항제 화합물
CN119137112A (zh) 2022-03-02 2024-12-13 免疫传感器治疗股份有限公司 喹啉cGAS拮抗剂化合物
WO2026050765A1 (en) 2024-08-30 2026-03-05 Immunesensor Therapeutics, Inc. Solid forms and salts of a quinoline cgas antagonist compound
WO2026057087A1 (zh) * 2024-09-14 2026-03-19 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542785A (en) * 1967-05-15 1970-11-24 Ciba Geigy Corp 2-hydroxy-4-aryl-quinolines
US3668207A (en) * 1970-01-22 1972-06-06 Ciba Geigy Corp 2-amino-4-aryl-quinolines
WO2004002960A1 (en) * 2002-06-27 2004-01-08 Schering Aktiengesellschaft Substituted quinoline ccr5 receptor antagonists
AU2008303602A1 (en) 2007-09-27 2009-04-02 F. Hoffmann-La Roche Ag Quinoline derivatives as 5HT5A receptor antagonists
JP2019501904A (ja) * 2015-12-14 2019-01-24 ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダFundacion Para La Investigasion Medica Aplicada Dnaメチルトランスフェラーゼの阻害剤としての2,4,6,7−四置換キノリン化合物
CN109111426B (zh) 2017-06-23 2021-12-14 中国科学院上海药物研究所 一类稠合双环杂芳基或芳基化合物,及其用途
IL302338B2 (en) 2017-09-08 2024-10-01 Univ Leland Stanford Junior Enpp1 inhibitors and their use for the treatment of cancer
WO2019241787A1 (en) 2018-06-15 2019-12-19 The Regents Of The University Of Colorado A Body Corporate Novel cyclic gmp-amp synthase (cgas) inhibitors and their method of use
US12064433B2 (en) 2018-07-27 2024-08-20 Arcus Biosciences, Inc. Pyridone A2R antagonists
EP3620164A1 (en) * 2018-09-05 2020-03-11 Genoscience Pharma SAS Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases
WO2020142735A1 (en) 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents
EP4076667A1 (en) 2019-12-20 2022-10-26 Erasca, Inc. Tricyclic pyridones and pyrimidones
CN115209883B (zh) 2020-01-20 2025-05-20 新月生物科学 新型细胞代谢调节化合物及其用途
JP2023532998A (ja) 2020-07-06 2023-08-01 クレセンタ バイオサイエンシズ 新規細胞代謝調節化合物およびそのウイルス性疾患の治療のための使用
KR20230062845A (ko) 2020-09-03 2023-05-09 이뮨센서 테라퓨틱스, 인코포레이티드 퀴놀린 cgas 길항제 화합물
CN119137112A (zh) 2022-03-02 2024-12-13 免疫传感器治疗股份有限公司 喹啉cGAS拮抗剂化合物

Similar Documents

Publication Publication Date Title
JP7530068B2 (ja) cGASアンタゴニスト化合物
AU2021336977A1 (en) Quinoline cGAS antagonist compounds
US12091387B2 (en) Quinoline cGAS antagonist compounds
JP6663857B2 (ja) ピラゾロピリジンおよびピラゾロピリミジン
KR20200065024A (ko) 화학적 화합물
CA2930414A1 (en) Tetrahydroquinoline compositions as bet bromodomain inhibitors
CA2899646A1 (en) Substituted xanthines and methods of use thereof
TW200843761A (en) 3-carbamoyl-2-pyridone derivatives
JP7777596B2 (ja) Cd38阻害剤としてのキノリン及びアザキノリン
US20250109119A1 (en) Ampk agonists and methods of use thereof
JPWO2023168367A5 (https=)
KR20250065917A (ko) Cgas 억제제로서의 트리아졸-치환된 이미다조[1,2-a]피리미딘
HK40120448A (zh) 喹啉cgas拮抗剂化合物
HK40094674A (zh) 喹啉cgas拮抗剂化合物
HK40063819B (zh) Tyk2抑制剂和其用途
HK40066535B (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
HK40066535A (zh) 磷咪唑并喹啉胺衍生物、及其药物组合物和应用
HK40043591B (zh) 用作ii型irak抑制剂的杂芳基化合物及其用途
HK40004439B (zh) Cgas拮抗剂化合物
HK40004439A (en) Cgas antagonist compounds
HK1234392A1 (en) Pyrazolopyridines and pyrazolopyrimidines